newsfilter
← Earnings
Earnings Releases·

Amarin Corporation plc — Q3 2026 Earnings Summary

Amarin Corporation plc reported a net income of $0.2 million for the third quarter of 2026, marking its first profitable quarter in over two years. Total net revenue for the period was $39.6 million, driven by a 139% increase in licensing and royalty revenue to $2.7 million, while U.S. product revenue declined by 30% due to generic competition. The company maintained a debt-free balance sheet with cash, cash equivalents, and short-term investments totaling $323.4 million and reported positive free cash flow for the fourth consecutive quarter. Additionally, in-market demand for VASCEPA/VAZKEPA grew by an estimated 68% in Europe and 55% globally compared to the same period in 2025.

Company
AMARIN CORP PLC
Sector
Healthcare
Industry
Drug Manufacturers - General